Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.
Latest updates to the Cardiol Therapeutics Press Releases page
- Check5 days agoChange DetectedThe left sidebar stock price updated to $1.01 NASDAQ:CRDL, and the previous $1.03 entry has been removed. This reflects updated pricing data for Cardiol Therapeutics on the investor information page.SummaryDifference0.2%
- Check12 days agoChange DetectedStock price values in the investor widget updated to $1.03 (NASDAQ) and $1.40 (TSX); footer copyright year updated from 2025 to 2026.SummaryDifference0.7%
- Check19 days agoChange DetectedStock pricing data in the header was updated: NASDAQ price is now $1.0001 as of December 1, 2025 and TSX price is $1.39, replacing $0.9401 and $1.30 on November 29, 2025.SummaryDifference0.7%
- Check26 days agoChange DetectedAdded a new press release headline about ARCHER trial data dated November 29, 2025 and updated stock prices to 0.9401 and 1.30. Removed the May 27, 2025 AGM webcast entry (May 28th webcast).SummaryDifference1%
- Check33 days agoChange DetectedStock price values in the investor sidebar updated from $1.02 and $1.44 to $0.973 and $1.38.SummaryDifference0.5%
- Check40 days agoChange DetectedAdded a new press release headline 'Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040' (Nov 13, 2025); stock price updated to $1.44. Removed the older press release about nominating Dr. Timothy Garnett to the Board of Directors (Apr 29, 2025).SummaryDifference1%
Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.